EX-23.1 7 tm2531084d2_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3, of Black Diamond Therapeutics, Inc. of our report dated March 6, 2025 relating to the financial statements, which appears in Black Diamond Therapeutics, Inc. 's Annual Report on Form 10-K for the year ended December 31, 2024. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
November 13, 2025